Suppr超能文献

[尿游离多巴胺作为肾功能标志物的应用及与其他肾脏标志物的比较]

[Application of urinary free dopamine as a marker of renal function, and comparison with other renal marker].

作者信息

Komori T, Habuchi Y, Inoue H, Sakai T, Suzuki K, Ohtsuka K, Tanaka H, Fujita N, Yoshimura M

机构信息

Clinical Laboratory Unit of University Hospital, Kyoto Prefectural University of Medicine.

出版信息

Rinsho Byori. 1997 Jul;45(7):679-84.

PMID:9256016
Abstract

Urinary free dopamine (U-f-DA) is derived from renal DA synthesized in the renal proximal tubules, and plays an important role for diuresis and natriuresis. We were previously reported that U-f-DA was the superior marker of renal function as compared with ordinary methods including alpha 1-microglobulin (U-alpha 1 MG), beta 2-microglobulin (U-beta 2 MG) and N-acetyl-beta-D-glucosaminidase (U-NAG) in spot urine samples. U-f-DA can be used as index for the evaluation of renal transplantation. In order to evaluate the clinical usefulness of U-f-DA as a marker of renal function, we investigated as follows; firstly, the age related changes of U-f-DA in healthy out-patients, secondly, the correlation between U-f-DA and creatinine clearance (CCr), serum creatinine (S-Cr) in in-patients, and thirdly, the chronological changes of U-f-DA, U-alpha 1 MG, U-beta 2 MG, CCr and S-Cr in patients with chronic renal failure before and after renal transplantation. There is no age-related changes in U-f-DA from patients with 3 years to 88 years old. U-f-DA was positively correlated with CCr and negatively correlated with S-Cr. There are parallel changes of U-f-DA and CCr in increasing direction, on the other hand, parallel changes of U-alpha 1 MG, U-beta 2 MG and S-Cr in decreasing direction after renal transplantation. In patients with post renal transplantation who were not well controlled, S-Cr increased gradually with the decreasing level of U-f-DA. These results suggest that the measurement of U-f-DA in spot urine samples is useful marker for evaluation of the renal function and can be used an index of viability of the transplanted kidney.

摘要

尿游离多巴胺(U-f-DA)来源于肾近端小管合成的肾多巴胺,对利尿和利钠起着重要作用。我们之前报道过,与随机尿样中包括α1-微球蛋白(U-α1 MG)、β2-微球蛋白(U-β2 MG)和N-乙酰-β-D-氨基葡萄糖苷酶(U-NAG)在内的常规方法相比,U-f-DA是肾功能的更佳标志物。U-f-DA可作为评估肾移植的指标。为了评估U-f-DA作为肾功能标志物的临床实用性,我们进行了如下研究:首先,调查健康门诊患者中U-f-DA的年龄相关变化;其次,研究住院患者中U-f-DA与肌酐清除率(CCr)、血清肌酐(S-Cr)之间的相关性;第三,观察慢性肾衰竭患者肾移植前后U-f-DA、U-α1 MG、U-β2 MG、CCr和S-Cr的时间变化。3岁至88岁患者的U-f-DA无年龄相关变化。U-f-DA与CCr呈正相关,与S-Cr呈负相关。肾移植后,U-f-DA和CCr呈同向平行变化,而U-α1 MG、U-β2 MG和S-Cr呈反向平行变化。在肾移植后病情控制不佳的患者中,S-Cr随着U-f-DA水平的降低而逐渐升高。这些结果表明,检测随机尿样中的U-f-DA是评估肾功能的有用标志物,可作为移植肾存活的指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验